Načítá se...
A Point‐by‐Point Response to Recent Arguments Against the Use of Statins in Primary Prevention: This Statement is Endorsed by the American Society for Preventive Cardiology
Recently, a debate over the merits of statin therapy in primary prevention was published in the Wall Street Journal. The statin opponent claimed that statins should only be used in secondary prevention and never in any primary‐prevention patients at risk for cardiovascular events. In this evidence‐b...
Uloženo v:
| Vydáno v: | Clin Cardiol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley Periodicals, Inc.
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652642/ https://ncbi.nlm.nih.gov/pubmed/22674150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22016 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|